Related Articles
Clinical impacts of severe thrombocytopenia in the first cycle of azacitidine monotherapy and cytogenetics in patients with myelodysplastic syndrome: The Kyoto Conditional Survival Scoring System
Mechanisms and potential molecular markers of early response to combination epigenetic therapy in patients with myeloid malignancies
HYPERFIBROTIC MYELODYSPLASIA - A POSSIBLE NEW ENTITY (REVIEW)
Effects of decitabine on megakaryocyte maturation in patients with myelodysplastic syndromes
Methylation and expression of mismatch repair gene human mutS homolog 2 in myelodysplastic syndromes